Cartesian Therapeutics, Inc. Temporary Equity, Dividends, Adjustment
Cartesian Therapeutics, Inc. (RNAC) reported Temporary Equity, Dividends, Adjustment of $0 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityDividendsAdjustment · last filed 2016-11-10
- Cartesian Therapeutics, Inc. temporary equity, dividends, adjustment for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. temporary equity, dividends, adjustment for the quarter ending 2016-06-30 was $2.21M, a 41.49% increase year-over-year.
- Cartesian Therapeutics, Inc. temporary equity, dividends, adjustment for the quarter ending 2015-09-30 was $1.84M.
- Cartesian Therapeutics, Inc. temporary equity, dividends, adjustment for the quarter ending 2015-06-30 was $1.56M.
| Period end | Temporary Equity, Dividends, Adjustment 3 month | Temporary Equity, Dividends, Adjustment 6 month | Temporary Equity, Dividends, Adjustment 9 month |
|---|---|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | $2.21M derived: sum of 2 quarters · filed 2016-11-10 | $4.57M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.21M 10-Q · filed 2016-08-09 | $4.57M 10-Q · filed 2016-08-09 | |
| 2015-09-30 | $1.84M 10-Q · filed 2016-11-10 | $3.40M derived: sum of 2 quarters · filed 2016-11-10 | $4.96M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $1.56M 10-Q · filed 2016-08-09 | $3.12M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |